Intracavitary injection of OK-432 for malignant pericardial effusion, a case report.
The clinical efficacy of OK-432 has been evaluated favorably when administered for malignant effusion in pleural and peritoneal cavities. It may be effective also in pericardial space in response to inflammation or tumor, i.e., in weep fluid, but there are few reports of the clinical efficacy of a single administration of this agent in this space. We present here a case of spontaneous remission of malignant pericardial effusion after a single injection of OK-432 into the pericardial space.